Page 39 - Calendario Vaccinale 2019

Bibliografia essenziale

1) Brisson M, Bénard É, Drolet M, Bogaards JA, Baussano I, Vänskä S et al. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination:
a systematic review and meta-analysis of predictions from transmission-dynamic models. Lancet Public Health 2016; 1: e8-e17.

2) Drolet M, Laprise JF, Brotherton JML, Donovan B, Fairley CK, Ali H et al. The Impact of Human Papillomavirus Catch-Up Vaccination in Australia: Implications for
introduction of multiple age cohort vaccination and postvaccination data interpretation.

3) Drolet M, Bénard É, Boily MC, Ali H, Baandrup L, Bauer H et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a
systematic review and meta-analysis. Lancet Infect Dis. 2015;15: 565-80.

4) Osservatorio Nazionale Screening – Gruppo Italiano Screening del Cervicocarcinoma (GISCi). Consenus Conference per la definizione del percorso di screening del
cervicocarcinoma nelle donne vaccinazte contro l’HPV, pp. 1-87 (2016).

5) Ghelardi A, Parazzini F, Martella F, Pieralli A, Bay P, Tonetti A et al. SPERANZA project: HPV vaccination after treatment for CIN2+. Gynecologic Oncology 2018; 151:
229-234.

6) Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with
cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012; 344: e1401.

7) Arbyn M, Xu L. Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev. of Vaccines 2018; 17:1085-1091
8) Scheller NM, Pasternak B, Mølgaard-Nielsen D, Svanström H, Hviid A. Quadrivalent HPV Vaccination and the Risk of Adverse Pregnancy Outcomes. N Engl J Med.

2017; 376:1223-1233.

Calendario vaccinale per la vita (4° Edizione 2019) 39/44